Reader View AI Reader View Regeneron Has $16 Billion in Net Cash and Trades Near 20 Times Earnings. Is It the Cheapest Big Biotech? www.nasdaq.com · November 14, 2026 · 12:25 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link